Request for Covid-19 Impact Assessment of this Report
The United States Prescription Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Prescription Drugs market, reaching US$ million by the year 2028. As for the Europe Prescription Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Prescription Drugs players cover Pfizer, Roche, Sanofi, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Brand Drugs
Generic Drug
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Takeda
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prescription Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Prescription Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Prescription Drugs by Country/Region, 2017, 2022 & 2028
2.2 Prescription Drugs Segment by Type
2.2.1 Brand Drugs
2.2.2 Generic Drug
2.3 Prescription Drugs Sales by Type
2.3.1 Global Prescription Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Prescription Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Prescription Drugs Sale Price by Type (2017-2022)
2.4 Prescription Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Prescription Drugs Sales by Application
2.5.1 Global Prescription Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Prescription Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Prescription Drugs Sale Price by Application (2017-2022)
3 Global Prescription Drugs by Company
3.1 Global Prescription Drugs Breakdown Data by Company
3.1.1 Global Prescription Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Prescription Drugs Sales Market Share by Company (2020-2022)
3.2 Global Prescription Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Prescription Drugs Revenue by Company (2020-2022)
3.2.2 Global Prescription Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Prescription Drugs Sale Price by Company
3.4 Key Manufacturers Prescription Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prescription Drugs Product Location Distribution
3.4.2 Players Prescription Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Prescription Drugs by Geographic Region
4.1 World Historic Prescription Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Prescription Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Prescription Drugs Annual Revenue by Geographic Region
4.2 World Historic Prescription Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Prescription Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Prescription Drugs Annual Revenue by Country/Region
4.3 Americas Prescription Drugs Sales Growth
4.4 APAC Prescription Drugs Sales Growth
4.5 Europe Prescription Drugs Sales Growth
4.6 Middle East & Africa Prescription Drugs Sales Growth
5 Americas
5.1 Americas Prescription Drugs Sales by Country
5.1.1 Americas Prescription Drugs Sales by Country (2017-2022)
5.1.2 Americas Prescription Drugs Revenue by Country (2017-2022)
5.2 Americas Prescription Drugs Sales by Type
5.3 Americas Prescription Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prescription Drugs Sales by Region
6.1.1 APAC Prescription Drugs Sales by Region (2017-2022)
6.1.2 APAC Prescription Drugs Revenue by Region (2017-2022)
6.2 APAC Prescription Drugs Sales by Type
6.3 APAC Prescription Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Prescription Drugs by Country
7.1.1 Europe Prescription Drugs Sales by Country (2017-2022)
7.1.2 Europe Prescription Drugs Revenue by Country (2017-2022)
7.2 Europe Prescription Drugs Sales by Type
7.3 Europe Prescription Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prescription Drugs by Country
8.1.1 Middle East & Africa Prescription Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Prescription Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Prescription Drugs Sales by Type
8.3 Middle East & Africa Prescription Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prescription Drugs
10.3 Manufacturing Process Analysis of Prescription Drugs
10.4 Industry Chain Structure of Prescription Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prescription Drugs Distributors
11.3 Prescription Drugs Customer
12 World Forecast Review for Prescription Drugs by Geographic Region
12.1 Global Prescription Drugs Market Size Forecast by Region
12.1.1 Global Prescription Drugs Forecast by Region (2023-2028)
12.1.2 Global Prescription Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Prescription Drugs Forecast by Type
12.7 Global Prescription Drugs Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Prescription Drugs Product Offered
13.1.3 Pfizer Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Prescription Drugs Product Offered
13.2.3 Roche Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Prescription Drugs Product Offered
13.3.3 Sanofi Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Prescription Drugs Product Offered
13.4.3 Johnson & Johnson Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Merck & Co. (MSD)
13.5.1 Merck & Co. (MSD) Company Information
13.5.2 Merck & Co. (MSD) Prescription Drugs Product Offered
13.5.3 Merck & Co. (MSD) Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Merck & Co. (MSD) Main Business Overview
13.5.5 Merck & Co. (MSD) Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Prescription Drugs Product Offered
13.6.3 Novartis Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 AbbVie
13.7.1 AbbVie Company Information
13.7.2 AbbVie Prescription Drugs Product Offered
13.7.3 AbbVie Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 AbbVie Main Business Overview
13.7.5 AbbVie Latest Developments
13.8 Gilead Sciences
13.8.1 Gilead Sciences Company Information
13.8.2 Gilead Sciences Prescription Drugs Product Offered
13.8.3 Gilead Sciences Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Gilead Sciences Main Business Overview
13.8.5 Gilead Sciences Latest Developments
13.9 GlaxoSmithKline (GSK)
13.9.1 GlaxoSmithKline (GSK) Company Information
13.9.2 GlaxoSmithKline (GSK) Prescription Drugs Product Offered
13.9.3 GlaxoSmithKline (GSK) Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 GlaxoSmithKline (GSK) Main Business Overview
13.9.5 GlaxoSmithKline (GSK) Latest Developments
13.10 Amgen
13.10.1 Amgen Company Information
13.10.2 Amgen Prescription Drugs Product Offered
13.10.3 Amgen Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Amgen Main Business Overview
13.10.5 Amgen Latest Developments
13.11 AstraZeneca
13.11.1 AstraZeneca Company Information
13.11.2 AstraZeneca Prescription Drugs Product Offered
13.11.3 AstraZeneca Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 AstraZeneca Main Business Overview
13.11.5 AstraZeneca Latest Developments
13.12 Bristol-Myers Squibb
13.12.1 Bristol-Myers Squibb Company Information
13.12.2 Bristol-Myers Squibb Prescription Drugs Product Offered
13.12.3 Bristol-Myers Squibb Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Bristol-Myers Squibb Main Business Overview
13.12.5 Bristol-Myers Squibb Latest Developments
13.13 Eli Lilly
13.13.1 Eli Lilly Company Information
13.13.2 Eli Lilly Prescription Drugs Product Offered
13.13.3 Eli Lilly Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Eli Lilly Main Business Overview
13.13.5 Eli Lilly Latest Developments
13.14 Teva
13.14.1 Teva Company Information
13.14.2 Teva Prescription Drugs Product Offered
13.14.3 Teva Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Teva Main Business Overview
13.14.5 Teva Latest Developments
13.15 Bayer
13.15.1 Bayer Company Information
13.15.2 Bayer Prescription Drugs Product Offered
13.15.3 Bayer Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Bayer Main Business Overview
13.15.5 Bayer Latest Developments
13.16 Novo Nordisk
13.16.1 Novo Nordisk Company Information
13.16.2 Novo Nordisk Prescription Drugs Product Offered
13.16.3 Novo Nordisk Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Novo Nordisk Main Business Overview
13.16.5 Novo Nordisk Latest Developments
13.17 Allergan
13.17.1 Allergan Company Information
13.17.2 Allergan Prescription Drugs Product Offered
13.17.3 Allergan Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Allergan Main Business Overview
13.17.5 Allergan Latest Developments
13.18 Takeda
13.18.1 Takeda Company Information
13.18.2 Takeda Prescription Drugs Product Offered
13.18.3 Takeda Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Takeda Main Business Overview
13.18.5 Takeda Latest Developments
13.19 Boehringer Ingelheim
13.19.1 Boehringer Ingelheim Company Information
13.19.2 Boehringer Ingelheim Prescription Drugs Product Offered
13.19.3 Boehringer Ingelheim Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Boehringer Ingelheim Main Business Overview
13.19.5 Boehringer Ingelheim Latest Developments
13.20 Takeda
13.20.1 Takeda Company Information
13.20.2 Takeda Prescription Drugs Product Offered
13.20.3 Takeda Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Takeda Main Business Overview
13.20.5 Takeda Latest Developments
14 Research Findings and Conclusion
Table 1. Prescription Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Prescription Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Brand Drugs
Table 4. Major Players of Generic Drug
Table 5. Global Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 6. Global Prescription Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Prescription Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Prescription Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Prescription Drugs Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 11. Global Prescription Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Prescription Drugs Revenue by Application (2017-2022)
Table 13. Global Prescription Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Prescription Drugs Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Prescription Drugs Sales by Company (2020-2022) & (K Units)
Table 16. Global Prescription Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Prescription Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Prescription Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Prescription Drugs Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Prescription Drugs Producing Area Distribution and Sales Area
Table 21. Players Prescription Drugs Products Offered
Table 22. Prescription Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Prescription Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Prescription Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Prescription Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Prescription Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Prescription Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Prescription Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Prescription Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Prescription Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 34. Americas Prescription Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Prescription Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Prescription Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 38. Americas Prescription Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 40. Americas Prescription Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Prescription Drugs Sales by Region (2017-2022) & (K Units)
Table 42. APAC Prescription Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Prescription Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Prescription Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 46. APAC Prescription Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 48. APAC Prescription Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 50. Europe Prescription Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Prescription Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Prescription Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 54. Europe Prescription Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 56. Europe Prescription Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Prescription Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Prescription Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Prescription Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Prescription Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Prescription Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Prescription Drugs
Table 66. Key Market Challenges & Risks of Prescription Drugs
Table 67. Key Industry Trends of Prescription Drugs
Table 68. Prescription Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Prescription Drugs Distributors List
Table 71. Prescription Drugs Customer List
Table 72. Global Prescription Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Prescription Drugs Sales Market Forecast by Region
Table 74. Global Prescription Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Prescription Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Prescription Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Prescription Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Prescription Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Prescription Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Prescription Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Prescription Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Prescription Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Prescription Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Prescription Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Prescription Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Prescription Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Prescription Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Prescription Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Prescription Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Prescription Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Prescription Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. Pfizer Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Prescription Drugs Product Offered
Table 94. Pfizer Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Roche Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Roche Prescription Drugs Product Offered
Table 99. Roche Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Roche Main Business
Table 101. Roche Latest Developments
Table 102. Sanofi Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Prescription Drugs Product Offered
Table 104. Sanofi Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Sanofi Main Business
Table 106. Sanofi Latest Developments
Table 107. Johnson & Johnson Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Johnson & Johnson Prescription Drugs Product Offered
Table 109. Johnson & Johnson Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Johnson & Johnson Main Business
Table 111. Johnson & Johnson Latest Developments
Table 112. Merck & Co. (MSD) Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Merck & Co. (MSD) Prescription Drugs Product Offered
Table 114. Merck & Co. (MSD) Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Merck & Co. (MSD) Main Business
Table 116. Merck & Co. (MSD) Latest Developments
Table 117. Novartis Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Novartis Prescription Drugs Product Offered
Table 119. Novartis Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Novartis Main Business
Table 121. Novartis Latest Developments
Table 122. AbbVie Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. AbbVie Prescription Drugs Product Offered
Table 124. AbbVie Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. AbbVie Main Business
Table 126. AbbVie Latest Developments
Table 127. Gilead Sciences Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Gilead Sciences Prescription Drugs Product Offered
Table 129. Gilead Sciences Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Gilead Sciences Main Business
Table 131. Gilead Sciences Latest Developments
Table 132. GlaxoSmithKline (GSK) Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. GlaxoSmithKline (GSK) Prescription Drugs Product Offered
Table 134. GlaxoSmithKline (GSK) Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. GlaxoSmithKline (GSK) Main Business
Table 136. GlaxoSmithKline (GSK) Latest Developments
Table 137. Amgen Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Amgen Prescription Drugs Product Offered
Table 139. Amgen Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Amgen Main Business
Table 141. Amgen Latest Developments
Table 142. AstraZeneca Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. AstraZeneca Prescription Drugs Product Offered
Table 144. AstraZeneca Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. AstraZeneca Main Business
Table 146. AstraZeneca Latest Developments
Table 147. Bristol-Myers Squibb Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Bristol-Myers Squibb Prescription Drugs Product Offered
Table 149. Bristol-Myers Squibb Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. Bristol-Myers Squibb Main Business
Table 151. Bristol-Myers Squibb Latest Developments
Table 152. Eli Lilly Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Eli Lilly Prescription Drugs Product Offered
Table 154. Eli Lilly Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 155. Eli Lilly Main Business
Table 156. Eli Lilly Latest Developments
Table 157. Teva Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Teva Prescription Drugs Product Offered
Table 159. Teva Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 160. Teva Main Business
Table 161. Teva Latest Developments
Table 162. Bayer Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Bayer Prescription Drugs Product Offered
Table 164. Bayer Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 165. Bayer Main Business
Table 166. Bayer Latest Developments
Table 167. Novo Nordisk Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 168. Novo Nordisk Prescription Drugs Product Offered
Table 169. Novo Nordisk Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 170. Novo Nordisk Main Business
Table 171. Novo Nordisk Latest Developments
Table 172. Allergan Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 173. Allergan Prescription Drugs Product Offered
Table 174. Allergan Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 175. Allergan Main Business
Table 176. Allergan Latest Developments
Table 177. Takeda Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 178. Takeda Prescription Drugs Product Offered
Table 179. Takeda Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 180. Takeda Main Business
Table 181. Takeda Latest Developments
Table 182. Boehringer Ingelheim Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 183. Boehringer Ingelheim Prescription Drugs Product Offered
Table 184. Boehringer Ingelheim Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 185. Boehringer Ingelheim Main Business
Table 186. Boehringer Ingelheim Latest Developments
Table 187. Takeda Basic Information, Prescription Drugs Manufacturing Base, Sales Area and Its Competitors
Table 188. Takeda Prescription Drugs Product Offered
Table 189. Takeda Prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 190. Takeda Main Business
Table 191. Takeda Latest Developments
List of Figures
Figure 1. Picture of Prescription Drugs
Figure 2. Prescription Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prescription Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Prescription Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Prescription Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Brand Drugs
Figure 10. Product Picture of Generic Drug
Figure 11. Global Prescription Drugs Sales Market Share by Type in 2021
Figure 12. Global Prescription Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Prescription Drugs Consumed in Hospital
Figure 14. Global Prescription Drugs Market: Hospital (2017-2022) & (K Units)
Figure 15. Prescription Drugs Consumed in Clinic
Figure 16. Global Prescription Drugs Market: Clinic (2017-2022) & (K Units)
Figure 17. Prescription Drugs Consumed in Other
Figure 18. Global Prescription Drugs Market: Other (2017-2022) & (K Units)
Figure 19. Global Prescription Drugs Sales Market Share by Application (2017-2022)
Figure 20. Global Prescription Drugs Revenue Market Share by Application in 2021
Figure 21. Prescription Drugs Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Prescription Drugs Revenue Market Share by Company in 2021
Figure 23. Global Prescription Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Prescription Drugs Revenue Market Share by Geographic Region in 2021
Figure 25. Global Prescription Drugs Sales Market Share by Region (2017-2022)
Figure 26. Global Prescription Drugs Revenue Market Share by Country/Region in 2021
Figure 27. Americas Prescription Drugs Sales 2017-2022 (K Units)
Figure 28. Americas Prescription Drugs Revenue 2017-2022 ($ Millions)
Figure 29. APAC Prescription Drugs Sales 2017-2022 (K Units)
Figure 30. APAC Prescription Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Europe Prescription Drugs Sales 2017-2022 (K Units)
Figure 32. Europe Prescription Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Prescription Drugs Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Prescription Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Americas Prescription Drugs Sales Market Share by Country in 2021
Figure 36. Americas Prescription Drugs Revenue Market Share by Country in 2021
Figure 37. United States Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Prescription Drugs Sales Market Share by Region in 2021
Figure 42. APAC Prescription Drugs Revenue Market Share by Regions in 2021
Figure 43. China Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Prescription Drugs Sales Market Share by Country in 2021
Figure 50. Europe Prescription Drugs Revenue Market Share by Country in 2021
Figure 51. Germany Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Prescription Drugs Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Prescription Drugs Revenue Market Share by Country in 2021
Figure 58. Egypt Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Prescription Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Prescription Drugs in 2021
Figure 64. Manufacturing Process Analysis of Prescription Drugs
Figure 65. Industry Chain Structure of Prescription Drugs
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...